Chronic hepatitis B, Chronic hepatitis C
Adult: 1.6 mg twice wkly, up to 12 mth; for patients <40 kg: 40 mcg/kg. To be used alone or with interferon for chronic hepatitis B; and with interferon for chronic hepatitis C.
Indications and Dosage
Subcutaneous
Chronic hepatitis B, Chronic hepatitis C Adult: 1.6 mg twice wkly, up to 12 mth; for patients <40 kg: 40 mcg/kg. To be used alone or with interferon for chronic hepatitis B; and with interferon for chronic hepatitis C.
|
Reconstitution
Reconstitute the powder with 1 ml of the provided diluent (sterile water for inj) before admin.
|
Contraindications
Patients who are deliberately immunosuppressed e.g. organ transplant patients.
|
Special Precautions
Caution when used with other immunomodulating drugs.
|
Adverse Reactions
Local discomfort at the inj site, erythema, transient muscle atrophy, rash, polyarthralgia with hand oedema.
|
Action
Description: Thymalfasin is a thymus hormone. It exerts its immunomodulating effects mainly by enhancing the T cell activity. It may be used alone or with interferon as an immunomodulator for the treatment of chronic hepatitis B and C.
Pharmacokinetics: Excretion: Half-life: About 2 hr. |
Storage
Store between 2-8°C. Reconstituted inj should be used immediately.
|
MIMS Class
|